Circulating tumor DNA, metastatic colorectal cancer, Palliative chemotherapy, Longitudinal, Clinical utility
Rectal cancer, tumor immune microenvironment, Chemoradiotherapy, prognosis
Keywords: Breast cancer, HER2-low, HER2-zero, complete pathologic response, prognosis